PTC THERAPEUTICS INC (PTCT) Forecast, Price Target & Analyst Ratings

NASDAQ:PTCT • US69366J2006

Current stock price

65.3 USD
-1.78 (-2.65%)
At close:
65.3 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PTC THERAPEUTICS INC (PTCT).

Forecast Snapshot

Consensus Price Target

Price Target
$88.67
+ 35.79% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.49
Revenue Estimate
229.69M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
79.09%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$88.67
Upside
+ 35.79%
From current price of $65.30 to mean target of $88.67, Based on 22 analyst forecasts
Low
$60.60
Median
$87.72
High
$130.20

Price Target Revisions

1 Month
-0.38%
3 Months
6.36%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for PTCT. The average price target is 88.67 USD. This implies a price increase of 35.79% is expected in the next year compared to the current price of 65.3.
The average price target has been revised upward by 6.36% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PTCT Current Analyst RatingPTCT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

PTCT Historical Analyst RatingsPTCT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
79.09%
PTCT was analyzed by 22 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about PTCT.
In the previous month the buy percentage consensus was at a similar level.
PTCT was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-23Morgan StanleyMaintains Overweight -> Overweight
2026-02-20RBC CapitalMaintains Sector Perform -> Sector Perform
2026-02-20Wells FargoMaintains Overweight -> Overweight
2026-02-20B of A SecuritiesMaintains Buy -> Buy
2026-01-28BarclaysUpgrade Equal-Weight -> Overweight
2025-12-01RBC CapitalDowngrade Outperform -> Sector Perform
2025-11-06BarclaysMaintains Equal-Weight -> Equal-Weight
2025-11-05TD CowenMaintains Hold -> Hold
2025-11-05RBC CapitalMaintains Outperform -> Outperform
2025-11-05Wells FargoMaintains Overweight -> Overweight
2025-11-05Goldman SachsMaintains Sell -> Sell
2025-11-05CitigroupMaintains Neutral -> Neutral
2025-10-28JefferiesMaintains Buy -> Buy
2025-09-03Cantor FitzgeraldReiterate Overweight -> Overweight
2025-08-20Wells FargoMaintains Overweight -> Overweight
2025-08-20B of A SecuritiesMaintains Buy -> Buy
2025-08-20Morgan StanleyMaintains Overweight -> Overweight
2025-08-08RBC CapitalMaintains Outperform -> Outperform
2025-08-08Wells FargoMaintains Overweight -> Overweight
2025-07-29Cantor FitzgeraldMaintains Overweight -> Overweight
2025-07-29UBSMaintains Buy -> Buy
2025-07-29BarclaysMaintains Equal-Weight -> Equal-Weight
2025-07-29Wells FargoMaintains Overweight -> Overweight
2025-07-29Truist SecuritiesMaintains Buy -> Buy
2025-07-29B of A SecuritiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.49
Revenue Estimate
229.69M
Revenue Q2Q
-80.47%
EPS Q2Q
-104.92%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
14.09%
Revenue (3 Months)
12.16%
EPS (1 Month)
18.95%
EPS (3 Months)
21.89%

Next Earnings Summary

PTCT is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.49 USD and the consensus revenue estimate is 229.69M USD.
The next earnings revenue estimate has been revised upward by 12.16% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PTCT revenue by date.PTCT revenue by date.
937.822M
34.20%		806.78M
-13.97%		1.731B
114.51%		1.026B
-40.72%		1.224B
19.30%		1.513B
23.61%		1.593B
5.29%		1.703B
6.91%		1.689B
-0.82%		1.957B
15.87%		1.938B
-0.97%
EBITDA
YoY % growth
PTCT ebitda by date.PTCT ebitda by date.
14.888M
105.22%		-66.609M
-547.40%		896.123M
1,445.35%		154.46M
-82.76%		421.3M
172.76%		412.68M
-2.05%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
PTCT ebit by date.PTCT ebit by date.
-221.702M
46.45%		-142.272M
35.83%		857.308M
702.58%		73.829M
-91.39%		265.86M
260.10%		443.69M
66.89%		529.97M
19.45%		611.28M
15.34%		606.44M
-0.79%		703.7M
16.04%		627.02M
-10.90%
Operating Margin
PTCT operating margin by date.PTCT operating margin by date.
-23.64%-17.63%49.54%7.20%21.72%29.33%33.27%35.89%35.91%35.96%32.35%
EPS
YoY % growth
PTCT eps by date.PTCT eps by date.
-6.54
10.78%		-6.01
8.10%		7.74
228.79%		-0.65
-108.45%		1.40
314.51%		4.45
216.72%		4.78
7.61%		5.12
7.04%		5.50
7.37%		5.91
7.42%		6.25
5.87%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.49
-104.92%		-0.26
68.15%		-0.32
-257.74%		-0.26
84.29%		0.92
286.03%		1.28
582.29%		1.74
652.88%		2.17
928.15%
Revenue
Q2Q % growth		229.69M
-80.47%		224.01M
25.23%		245.69M
16.44%		272M
27.58%		414.34M
80.39%		463.92M
107.10%		516.91M
110.39%		552.79M
103.23%
EBITDA
Q2Q % growth		53.061M
-94.57%		76.694M
482.44%		57.283M
94.83%		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-10.136M
-101.04%		-3.251M
90.67%		2.447M
-29.85%		10.58M
112.96%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PTCT Yearly Revenue VS EstimatesPTCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
PTCT Yearly EPS VS EstimatesPTCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-16.87%
EPS Next 5 Year
-7.93%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-6.87%
Revenue Next 5 Year
-1.89%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-24.99%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PTC THERAPEUTICS INC / PTCT Forecast FAQ

What is the average price target for PTC THERAPEUTICS INC (PTCT) stock?

22 analysts have analysed PTCT and the average price target is 88.67 USD. This implies a price increase of 35.79% is expected in the next year compared to the current price of 65.3.

What is the next earnings date for PTCT stock?

PTC THERAPEUTICS INC (PTCT) will report earnings on 2026-05-04, after the market close.

Can you provide the consensus estimates for PTC THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of PTC THERAPEUTICS INC (PTCT) is -0.49 USD and the consensus revenue estimate is 229.69M USD.

How many analysts have analysed PTC THERAPEUTICS INC (PTCT)?

The number of analysts covering PTC THERAPEUTICS INC (PTCT) is 22.